✦ LIBER ✦

A Cost-Utility Analysis of Everolimus Plus Exemestane for the Treatment of ER+ HER2- Metastatic Breast Cancer in the United Kingdom

✍ Scribed by Taylor, M.; Lewis, L.; Vieira, J.; Chandiwana, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of everolimu

✍ Vakaramoko Diaby,Georges Adunlin… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 410 KB

Erratum to: Cost-effectiveness analysis

✍ Vakaramoko Diaby,Georges Adunlin… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 94 KB

PCN28 Budget Impact Analysis of Everolim

✍ Xie, J.; Diener, M.; De, G.; Wu, E.Q.; Namjoshi, M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

A Budgetary Impact Analysis Model for Ev

✍ Taylor, M.; Lewis, L.; Vieira, J.; Chandiwana, D. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost Utility Analysis of Everolimus in t

✍ Mihajlović, J.; Minović, I.; Bruinsma, A.; Postma, M.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

A Cost-Utility Analysis of Lighterlife T

✍ Lewis, L.; Taylor, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB